Epidemiological inference at the threshold of data availability: an influenza A(H1N2)v spillover event in the United Kingdom.

Autor: Fozard JA; MRC-University of Glasgow Centre for Virus Research , Glasgow, UK., Thomson EC; MRC-University of Glasgow Centre for Virus Research , Glasgow, UK.; Department of Clinical Research, London School of Hygiene and Tropical Medicine , London, UK., Illingworth CJR; MRC-University of Glasgow Centre for Virus Research , Glasgow, UK.

Publikováno v: Journal of the Royal Society, Interface [J R Soc Interface] 2024 Aug; Vol. 21 (217), pp. 20240168. Date of Electronic Publication: 2024 Aug 07.

Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection.

Autor: Illingworth CJR; MRC-University of Glasgow Centre for Virus Research, 464 Bearsden Road, Glasgow G61 1QH, UK., Guerra-Assuncao JA; Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street, London WC1N 3JH, UK.; Infection, Immunity and Inflammation Research and Teaching Department, University College London, Gower Street, London WC1E 6BT, UK., Gregg S; Infection, Immunity and Inflammation Research and Teaching Department, University College London, Gower Street, London WC1E 6BT, UK., Charles O; Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street, London WC1N 3JH, UK.; Infection, Immunity and Inflammation Research and Teaching Department, University College London, Gower Street, London WC1E 6BT, UK., Pang J; Infection, Immunity and Inflammation Research and Teaching Department, University College London, Gower Street, London WC1E 6BT, UK., Roy S; Infection, Immunity and Inflammation Research and Teaching Department, University College London, Gower Street, London WC1E 6BT, UK., Abdelnabi R; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven B-3000, Belgium.; The VirusBank Platform, Gaston Geenslaan, Leuven B-3000, Belgium., Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven B-3000, Belgium.; The VirusBank Platform, Gaston Geenslaan, Leuven B-3000, Belgium., Breuer J; Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street, London WC1N 3JH, UK.; Infection, Immunity and Inflammation Research and Teaching Department, University College London, Gower Street, London WC1E 6BT, UK.

Publikováno v: Virus evolution [Virus Evol] 2024 Jan 04; Vol. 10 (1), pp. veae001. Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2024).

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.

Autor: Brevini T; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK. tb647@cam.ac.uk., Maes M; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Webb GJ; Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., John BV; Division of Gastroenterology and Hepatology, University of Miami and Miami VA Health System, Miami, FL, USA., Fuchs CD; Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Buescher G; Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Wang L; Transplant and Regenerative Medicine Laboratory, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Griffiths C; Transplant and Regenerative Medicine Laboratory, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Brown ML; Transplant and Regenerative Medicine Laboratory, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Scott WE 3rd; Transplant and Regenerative Medicine Laboratory, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Pereyra-Gerber P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Gelson WTH; Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Brown S; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Dillon S; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Muraro D; Wellcome Sanger Institute, Hinxton, UK., Sharp J; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Neary M; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Box H; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Tatham L; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Stewart J; Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Curley P; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Pertinez H; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Forrest S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Gastroenterology and Hepatology, University of Miami and Miami VA Health System, Miami, FL, USA., Varankar SS; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Darvish-Damavandi M; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Mulcahy VL; Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK., Kuc RE; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Williams TL; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Heslop JA; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Rossetti D; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Tysoe OC; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Galanakis V; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Vila-Gonzalez M; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Crozier TWM; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Bargehr J; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Sinha S; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK., Upponi SS; Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Fear C; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Swift L; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Saeb-Parsy K; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Roy Calne Transplant Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Davies SE; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Wester A; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Hagström H; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Melum E; Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section of Gastroenterology, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Clements D; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Humphreys P; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Herriott J; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Kijak E; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Cox H; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Bramwell C; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Valentijn A; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Illingworth CJR; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK., Dahman B; Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, VA, USA., Bastaich DR; Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, VA, USA., Ferreira RD; Division of Gastroenterology and Hepatology, University of Miami and Miami VA Health System, Miami, FL, USA., Marjot T; Oxford Liver Unit, Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK., Barnes E; Oxford Liver Unit, Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK., Moon AM; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA., Barritt AS 4th; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Baker S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Davenport AP; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Corbett G; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Gorgoulis VG; Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.; Biomedical Research Foundation, Academy of Athens, Athens, Greece., Buczacki SJA; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Lee JH; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Matheson NJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA.; NHS Blood and Transplant, Cambridge, UK., Trauner M; Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Fisher AJ; Transplant and Regenerative Medicine Laboratory, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Gibbs P; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Roy Calne Transplant Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Butler AJ; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Roy Calne Transplant Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Watson CJE; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Roy Calne Transplant Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre, and the NIHR Blood and Transplant Research Unit (BTRU) at the University of Cambridge in collaboration with Newcastle University and in partnership with NHS Blood and Transplant (NHSBT), Cambridge, UK., Mells GF; Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK., Dougan G; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge, UK., Owen A; Centre of Excellence in Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Lohse AW; Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Vallier L; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK. ludovic.vallier@bih-charite.de.; Wellcome Sanger Institute, Hinxton, UK. ludovic.vallier@bih-charite.de.; Berlin Institute of Health (BIH), BIH Centre for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Berlin, Germany. ludovic.vallier@bih-charite.de.; Max Planck Institute for Molecular Genetics, Berlin, Germany. ludovic.vallier@bih-charite.de., Sampaziotis F; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK. fs347@cam.ac.uk.; Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. fs347@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. fs347@cam.ac.uk.

Publikováno v: Nature [Nature] 2023 Mar; Vol. 615 (7950), pp. 134-142. Date of Electronic Publication: 2022 Dec 05.

Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.

Autor: Kemp SA; Division of Infection and Immunity, University College London, London, UK., Collier DA; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir RP; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Ferreira IATM; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Gayed S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Jahun A; Department of Pathology, University of Cambridge, Cambridge, UK., Hosmillo M; Department of Pathology, University of Cambridge, Cambridge, UK., Rees-Spear C; Division of Infection and Immunity, University College London, London, UK., Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Lumb IU; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK., Roberts DJ; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK., Chandra A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Canterbury, UK., Sharrocks K; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Blane E; Department of Medicine, University of Cambridge, Cambridge, UK., Modis Y; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Leigh KE; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Briggs JAG; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., van Gils MJ; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Cambridge Bioresource, Cambridge, UK., Smith C; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK., Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; FES-Cuautitlán, UNAM, Cuautitlán Izcalli, Mexico., Pollock DD; Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA., Goldstein RA; Division of Infection and Immunity, University College London, London, UK., Smielewska A; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Skittrall JP; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, UK., Gouliouris T; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Goodfellow IG; Department of Pathology, University of Cambridge, Cambridge, UK., Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Illingworth CJR; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.

Publikováno v: Nature [Nature] 2022 Aug; Vol. 608 (7922), pp. E23.

An entropic safety catch controls hepatitis C virus entry and antibody resistance.

Autor: Stejskal L; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, United Kingdom.; Institute of Structural and Molecular Biology, Birkbeck College, London, United Kingdom., Kalemera MD; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, United Kingdom., Lewis CB; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom., Palor M; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, United Kingdom., Walker L; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, United Kingdom., Daviter T; Institute of Structural and Molecular Biology, Birkbeck College, London, United Kingdom.; Shared Research Facilities, The Institute of Cancer Research, London, United Kingdom., Lees WD; Institute of Structural and Molecular Biology, Birkbeck College, London, United Kingdom., Moss DS; Institute of Structural and Molecular Biology, Birkbeck College, London, United Kingdom., Kremyda-Vlachou M; Division of Infection and Immunity, University College London, London, United Kingdom., Kozlakidis Z; International Agency for Research on Cancer, World Health Organization, Lyon, France., Gallo G; The Pirbright Institute, Pirbright, United Kingdom., Bailey D; The Pirbright Institute, Pirbright, United Kingdom., Rosenberg W; Division of Medicine, Institute for Liver and Digestive Health, University College London, London, United Kingdom., Illingworth CJR; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.; Department of Genetics, University of Cambridge, Cambridge, United Kingdom.; Institut für Biologische Physik, Universität zu Köln, Cologne, Germany.; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom., Shepherd AJ; Institute of Structural and Molecular Biology, Birkbeck College, London, United Kingdom., Grove J; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, United Kingdom.; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Publikováno v: ELife [Elife] 2022 Jul 07; Vol. 11. Date of Electronic Publication: 2022 Jul 07.